Attention deficit hyperactivity disorder (ADHD) is a common childhood-onset behavioral disorder with a definite genetic component. The search for genes predisposing to ADHD has focused on genes involved in the regulation of monoamine systems. In this study, we emphasized genes that underlie various aspects of dopamine, norepinephrine and serotonin neurotransmissions and performed a comprehensive association analysis by screening with 245 single-nucleotide polymorphisms (SNPs) of 23 candidate genes in a sample of Chinese Han descent. A total of 182 DSM-IV ADHD children and 184 healthy controls were genotyped and analyzed with an average density of one SNP every 6.1 kb. Both single-SNP and multimarker haplotype analyses were implemented to exploit association signal for ADHD and its diagnostic subtypes. Empirical P-values were derived on the basis of 5000 permutations to evaluate gene-wide statistical significance. MAOA yielded highly suggestive evidence of association (empirical P < 0.01, OR = 1.94) with ADHD. For inattentive ADHD, MAOA, DDC and SYP showed suggestive evidence of association (empirical P < 0.05). ADRA2C achieved suggestive significance (empirical P < 0.05) for ADHD combined type. Additionally, for six genes (SNAP25, NET1, DBH, CHRNA4, DRD3 and SYT1) we detected one or more SNPs with nominal P-valuesp0.05. This study has identified several genes as promising susceptibility loci for ADHD. Replication efforts and further investigations remain necessary to provide definite proof of association.
Introduction
Attention deficit hyperactivity disorder (ADHD) is among the most common neurobehavioral disorders of child onset. 1 Family, twin and adoption studies indicate a definite genetic component to ADHD, which has a heritability of approximately 76%. 2 Over the past decade, candidate gene studies of ADHD have mainly targeted the catecholamine (CA) and serotonin (5-HT) systems, due to strong biological hypotheses that imbalances in monoaminergic neurotransmission underlie the pathophysiology of ADHD. Dopamine (DA) genes, in particular the dopamine D4 receptor gene (DRD4) and the dopamine transporter gene (DAT1, SLC6A3), have attracted the most attention because the stimulant medications, which treat ADHD, block dopaminergic reuptake. 3 Together with evidence from animal experiments, [4] [5] [6] neurobiological and neuroimaging studies, 7, 8 dopamine genes have been made attractive candidates for genetic studies in ADHD. Norepinephrine (NE) is prevalent in the prefrontal cortex and has been found to influence the inhibitory control characteristics of ADHD. 9 Some drugs showing efficacy in the treatment of ADHD selectively modulate noradrenergic function. 10 The consideration of serotonin genes as candidates is based on the role of serotonin for regulating the impulsivity and aggression seen in ADHD. 11, 12 Studies of the DAT knockout mouse model of ADHD 13 implicated serotonergic neurotransmission because the calming effect of psychostimulants was mediated by a serotonergic mechanism.
Molecular genetic studies have yielded some encouraging evidence that genes involved in the regulation of monaminergic neuronal networks may confer susceptibility to ADHD. 14 The most prominent findings in the current literature have been obtained from meta-analysis for the association of several single variants in seven candidate genes that have been replicated in three or more data sets: DAT1, DRD4, dopamine D5 receptor (DRD5), dopamine b-hydroxylase (DBH), serotonin transporter (5-HTT, SLC6A4), serotonin 1B receptor (HTR1B) and synaptosomal-associated protein 25 (SNAP25). As reviewed by Faraone et al., 2 these loci appear to elevate risk of ADHD, with modest but significant pooled odds ratios ranged from 1.1 to 1.5.
In the current study, we conducted an association analysis of 23 candidate genes involved in monoaminergic neurotransmission using a sample of 184 ADHD children and 184 healthy individuals of Chinese Han descent. We emphasized genes for enzymes, receptors and transporters of dopamine, norepinephrine and serotonin systems, as well as genes associated with synaptic vesicle neurotransmitter release.
Materials and methods

Clinical samples
A total of 184 ADHD youths were recruited from child psychiatric clinics of the Institute of Mental Health, Peking University from June 2004 to December 2005. This work was approved by the Ethics Committee of the Health Science Center, Peking University. We obtained written informed consent from parents of the ADHD youths.
Eligible cases for recruiting in the study met inclusion criteria as follows: (1) met DSM-IV ADHD diagnostic criteria, 15 (2) age between 6 and 16 years, (3) full-scale estimated IQ > 70 and (4) both biological parents were of Chinese Han descent. Individuals with major neurological handicaps, a diagnosis of schizophrenia, pervasive development disorder, epilepsy, mental retardation or other brain disorders were excluded.
Assessments and diagnoses
A semi-structured interview was conducted by psychiatrists with the parents and their offspring using the Clinical Diagnostic Interview Scale (CDIS). 16 The parent who best knew the child was regarded as the primary informant. To better evaluate the subjects' behaviors at school and elaborate on the questions for which supplementary information should be provided, teachers were administrated a questionnaire containing criteria for DSM-IV ADHD. Intelligence quotient was estimated using the Chinese-Wechsler Intelligence Scale for Children (C-WISC) 17 administrated by research assistants with master's degrees in psychiatry.
Final ADHD diagnosis was made by a senior child and adolescent psychiatrist through an exhaustive review of all available information about the symptoms and the associated impairments.
Control samples
A total of 184 normal controls were ascertained from healthy blood donors from the Blood Center of the First Hospital, Peking University and from healthy volunteers at our Institute. All were of Chinese Han descent. The exclusion criteria for controls were ADHD, other major psychiatric disorders, family history of psychosis, severe physical diseases and substance abuse.
To exclude possible ADHD, all participants were examined with the ADHD Rating Scale-IV (ADHD RS-IV). The 18 symptoms according to DSM-IV were scored for frequency of occurrence. Participants were asked to rate their symptoms and behaviors in childhood. Since adults may tend to underreport their childhood symptoms, 18 we chose to include individuals with at most three inattentive symptoms and three hyperactive/impulsive symptoms as non-ADHD controls. Individuals were excluded if they had four or more items rated 'often' or 'always' in either domain. Additionally, available clinical and detailed information were considered and provided from the participants.
Gene selection
We selected 23 candidate genes (Table 1) based on prior evidence from pharmacological and neurobiological investigations and previous association studies. We focused on genes regulating dopamine, norepinephrine and serotonin neurotransmission systems. In addition, genes that involved in synaptic vesicle function, cholinergic neurotransmitter pathways and neurodevelopment were also investigated.
SNP selection
We selected the most informative SNPs across each candidate gene on the basis of the public information available. Both the direct and the indirect association analyses of SNPs were used to screen for the significance signal. The list of SNPs selected in the International Multi-Centre ADHD Gene (IMAGE) screen offered the present work a prior approach to select tagging SNPs 19 and SNPs within known functional regions (see detailed description in the article of Brookes et al.) . 20 We checked this list of SNPs for the 23 genes and eliminated informatively redundant SNPs with the available polymorphic information of Han population in particular, by using Applied Biosystems SNPbrowser software version 3.0. The program provides a database containing millions genotyping data for the International HapMap Project validated SNPs and empirical LD blocks for African, African-American, Caucasian, Chinese and Japanese populations. On the basis of above selection process and the estimates of genotyping success rate on the Illumina platform for each SNP, 21 we finally selected a total of 384 SNPs in and around the 23 candidate genes (see Table 1 ).
Genotype assays and quality control Genomic DNA was extracted directly from blood using the standard protocols (Omega Bio-tek Inc., Doraville, GA, USA). We supplied 4 mg gDNA per sample at the concentration of 50 ng ml À1 and purity of
Multiple ADHD susceptibility genes among Chinese Han population L Guan et al 1.8-2.0 determined using PicoGreen. Each sample was genotyped at a multiplex level of 384 SNPs per well on a custom array using the Illumina highthroughput BeadArray technology. 22, 23 The assay products were hybridized to high-density, bead-based microarrays. The fluorescence signal generated from each genotype was imaged on a submicron-resolution scanner to produce genotypes.
Of the 384 SNPs initially attempted, 347 (90.4%) assays returned genotype calls across all samples. In addition to automatic calling of genotypes, Illumina genotyping platform supplied a quantitative quality measure known as GenCall score, which reflects the confidence of each genotype. It varies from 0 to 1, and correlates with accuracy of the genotyping call, 21, 24 such that the higher the value, the more reliable the genotype. GenCall scores of the 131 860 genotypes (347 Â 380, that is, 368 samples with the addition of 12 duplicate DNA samples) delivered by Illumina were higher than 0.25 in 99.71%, with a mean ( ± s.d.) of 0.72±0.13. We chose to exclude SNPs with a quality genotyping rate (that is, those with GenCall scores > 0.25) of < 98% among all samples. This threshold resulted in the exclusion of one lowerquality SNP in DRD2. Of the remaining 346 SNPs, 97 were either monomorphic or had a minor allele frequency (MAF) < 5% in our control samples; 249 (72.0%) SNPs with MAFX5% were retained for further analyses.
Of 368 DNA samples, we identified 2 (5.4%) ADHD samples that failed a sex screen with the use of X-and Y-linked polymorphisms. We removed them from subsequent analyses. To assess the data quality, 12 duplicate DNA samples and 4 blank controls were included in the screening panel. Up to 8328 (347 Â 24) duplicated genotype calls were produced, and all were 100% consistent. The random genotyping error rate was estimated as lower than 0.024% (1/4164). 
Data analysis
We assessed Hardy-Weinberg equilibrium (HWE) using HAPLOVIEW version 3.32. HWE tests were performed on the control group. We removed 4 SNPs that were out of HWE (P < 0.01) from the 249 SNPs with MAFX5%. We decided to test for association with DSM-IV ADHD and its diagnostic subtypes. Because of the small number of subjects with the hyperactive/impulsive subtype, separate analyses were performed for the inattentive and combined type, respectively.
Because males are hemizygous at X-linked loci, we planned to examine males and females separately for X-chromosome genes. However, given the small sample size of females recruited, association for X-linked markers was examined with males only.
Both single-SNP and multi-marker haplotype association analyses were implemented in HAPLOVIEW. For single-marker tests of association, the w 2 and nominal P-value for the allele frequencies in case vs. control were obtained. A total of 5000 permutations were performed to empirically estimate significance levels to correct for multiple testing bias at the genewide level.
For multi-marker haplotype-based association testing, we chose to execute haplotype analyses only for genes that contained one or more SNPs that had showed nominal evidence for association in singlemarker tests. This restriction aimed to minimize the potential for Type I error introduced by the multiple testing problem. HAPLOVIEW estimated the pairwise linkage disequilibrium (LD) statistics (D 0 and r
2
) and created graphical representations of the underlying haplotype block structure. 25 The default block definition applied in HAPLOVIEW was taken from Gabriel et al. 26 Haplotypes were estimated using an accelerated expectation-maximization (EM) algorithm, 27 which created highly accurate population frequency estimates of the phased haplotypes. We performed the haplotype association test on the set of blocks defined by the LD structure in a gene, as implemented in HAPLOVIEW. To evaluate the gene-wide statistical significance of the association results, empirical P-values at the haplotype level were derived on the basis of 5000 permutations. For X-chromosome genes, the current version of HAPLOVIEW cannot handle haplotype analysis well, so we calculated haplotype associations by running w 2 tests in SPSS 13.0 with the use of the haplotype estimates created by HAPLO-VIEW version 3.2. We adjusted for the significance values of X-chromosome haplotypes using the Bonferroni correction in which the number of independent tests was defined as the number of LD blocks in a gene. 28 
Results
The final data set comprised 182 ADHD children and 184 healthy individuals. Table 2 shows demographic features of the sample. A summary of the candidate genes and SNPs is provided in Table 1 .
Single SNP analyses
Ten genes contained one or more SNP that was nominally significant (Table 3) . For ADHD, MAOA and SNAP25 had unadjusted P-values < 0.01; DDC and ADRA2C had nominal P-values < 0.05. For inattentive ADHD (ADHD-I), DDC and MAOA had nominal P-valuesp0.01, and DBH, CHRNA4, SNAP25, SYT1 and SYP had Pp0.05. For combined type ADHD (ADHD-C), SNAP25 achieved a P-value < 0.01, and ADRA2C, NET1, DBH, DRD3 and SYT1 yielded nominal P-values < 0.05.
Permutation tests showed MAOA to have an empirical SNP P-value < 0.01 at the gene-wide level of significance for ADHD (P = 0.008, OR = 1.94) and ADRA2C to have an empirical P < 0.05 for ADHD-C (P = 0.042, OR = 1.62). For inattentive ADHD, three genes were detected with adjusted P-values < 0.05: MAOA (P = 0.018, OR = 2.24), DDC (P = 0.032, OR = 1.82) and SYP (P = 0.048, OR = 1.83).
Haplotype analyses
The results of haplotype-based association analyses for the genes located on autosomes are shown in Table 4 . We found nominal evidence of association for SNAP25 (P < 0.03) and DDC (P < 0.04) in ADHD; DDC (P < 0.01), SNAP25 (P < 0.04), CHRNA4 (P < 0.04) and DBH (P < 0.05) in ADHD-I; SNAP25 (P < 0.03), DBH (P < 0.04) and DRD3 (P < 0.04) in ADHD-C. All these Abbreviation: ADHD, attention deficit hyperactivity disorder. a M/F = male female ratio. b The age of the control group was not normally distributed so the statistic presented is the median.
Multiple ADHD susceptibility genes among Chinese Han population L Guan et al associated haplotypes contained SNPs that were nominally significant in single-marker tests. After permutation tests were implemented, no significant association was identifiable except that DDC reached marginal significance with an empirical P-value of 0.052 (OR = 1.68) for inattentive subtype ADHD. For MAOA, we observed that all 12 SNPs tested were in one haplotype block defined using the Gabriel method 26 and showed strong LD with an average r 2 of 0.94 across the region. Significant associations for ADHD and its inattentive subtype were identified in the MAOA haplotype analyses (P < 0.05, see Table 5 ).
Discussion
In a case-control sample of Chinese Han descent, we have completed a systematic screen of 23 candidate genes for ADHD. Most of genes we investigated are likely to exert an effect in monoaminergic neurotransmitter systems. Ten genes of potential interest for replication efforts and further exploration were identified: (1) 6 (MAOA, DDC, NET1, ADRA2C, DBH, and DRD3) of 16 monoamine-related functional genes; (2) 3 (SNAP25, SYP, and SYT1) out of 5 synaptic vesicle associated genes and (3) 1 nicotinic acetylcholine gene (CHRNA4). Four genes (MAOA, DDC, ADRA2C and SYP) exhibited suggestive significance with empirical P-values < 0.05, while MAOA yielded highly suggestive significance (empirical P < 0.01). To our knowledge, the current study is among the largest sets of association analysis in ADHD to date and represents the first high-density SNP screen for multiple candidate genes influencing ADHD among a single Asian ethnicity.
Due to the large set of SNPs tested, our analyses involved a considerable degree of multiple testing. In consideration of limiting the number of tests as far as possible, we restricted haplotype analysis to genes achieving nominal significance in single-marker tests and implemented a single approach of defining haplotype sets according to the LD structure in a gene. 26 Since there are diverse correlation structures across markers in the genes, a Bonferroni correction would be overly conservative. We chose to employ an empirical approach to judge the nominal significance of any evidence for association seen throughout this work. On the basis of a permutation procedure across each gene, we therefore provided adjustment for the number of tests at the gene-wide level with the SNP or haplotype empirical P-values. If the Bonferroni correction were adopted to adjust for the number of genes considered, an approximate correction of empirical P would be 0.0022 for experiment-wide significance at the 0.05 level. None of the markers would meet this stringent threshold in our analyses, while MAOA yielded the most-extreme evidence for association with an uncorrected empirical P-value of 0.008. Due to the risk of false-positive findings, interpretation of the association signals should be cautious. Nevertheless, all the genes included in this screen are of interest on the basis of varying prior biological rationale, and some of them have shown prior evidence of association among genetic studies in ADHD. Hence our data would have included at least one of the meaningful signals deserving further consideration, though replications in independent samples are needed to evaluate the potential role of the nominated genes in ADHD.
The most promising finding in the current study was seen for MAOA in both single-marker and haplotype analyses. We observed nominal associations with all of the 12 SNPs tested, among which 9 consecutive SNPs approached empirical significance with P < 0.02. The region containing these nine Abbreviation: ADHD, attention deficit hyperactivity disorder. a All the genes that achieved nominal significance (P < 0.05) of association in the haplotype analyses. b Nominal P-value for the most significant haplotype block within each gene. c The gene-wide significance value at the haplotype level estimated on the basis of 5000 permutations from HAPLOVIEW. d '-' = NT, not tested, since no SNP had showed nominal evidence for association in the single marker tests. SNPs spans approximately 31 kb, showing almost complete LD with an average r 2 around 0.99. Intriguingly, it is precisely the same region that Brookes and colleagues 20 identified in a sample of 776 Caucasian families, strongly suggesting that it is less likely a chance finding. Our earlier work (H Zhang et al., unpublished data) also detected the association signal in MAOA. In an independent sample of Han origin, Zhang et al. found that a haplotype consisted of the T allele of rs1801291 (identified in this paper as well), the 3-repeat allele of the VNTR, and the 941G allele showed significant overtransmission to probands (w 2 = 8.33, P = 0.004) and the three markers were in strong LD. This received support from a most recent study in a Taiwanese sample, 29 where increased transmission of a haplotype consisting of the VNTR 3-repeat allele and the 941G allele to ADHD cases was identified. Taken together, the replicated findings in independent study samples may reflect a same association signal. It is rational to suggest that a putative vulnerability locus conferring susceptibility to ADHD might exist within MAOA or in its neighboring linked region.
MAOA is considered as a strong candidate modification of neurotransmission in dopamine, norepinephrine and serotonin systems. 30 Dysregulation of monoamine pathways has long been implicated as one of the mechanisms involved in the etiology of ADHD. Several groups [31] [32] [33] [34] [35] [36] have set out to test whether MAOA confers risk for ADHD, however, definite conclusion has not yet been received. Our data may serve as a support for previous positive reports of linkage/association for MAOA, especially in Chinese Han population. 33, 37 In addition to MAOA, we also found that DDC, NET1, SNAP25, SYP and CHRNA4 exhibited evidence of association. All of these were also nominally significant in the IMAGE study. 20 DDC, which catalyzes the production of dopamine and serotonin, has been reported for association with ADHD for polymorphisms lying within exons 1 and 3 0 -end. 38 In this paper, we identified an empirically significant SNP in intron 9 and a haplotype with marginal gene-wide significance of 0.052. This haplotype block consisted of markers at introns 9, 10, 11 and encompassed the associated SNP (rs11575454) reported by Brookes et al. 20 NET1 is of higher interest because an effective medication for ADHD selectively targets norepinephrine transporter. 39 With our set of SNPs, NET1 achieved a high average density of one SNP per 0.67 kb, and a novel SNP association signal for rs36009 (intron 10) was seen. In the IMAGE analysis for the Gabriel method defined haplotypes, a block that contained this marker was found with Global-P of 0.084. 20 Moreover, in our sample one haplotype which encompasses the intron 5 SNP (rs11568324) implicated by IMAGE, 20 displayed a trend for association (nominal P = 0.055). SNAP25, which encodes a presynaptic plasma membrane protein essential for synaptic vesicle fusion and neurotransmitter release, has been suggested to be a strong candidate for ADHD based on that the coloboma mouse mutant leads to hyperactive phenotype similar to that of ADHD. 40 Emerging evidence from currently published association/linkage studies has further implicated SNAP25 in ADHD. 2 This work replicated previous reports of associations for the regions of 3 0 -untranslated region (UTR), introns 1 and 7, [41] [42] [43] [44] [45] although a different set of variants were included. There is, however, a lack of overlap with the associated SNPs identified in the IMAGE sample. SYP is a synaptic vesicle associated gene as well. We detected a significant association signal for the very SNP reported by Brookes and colleagues. 20 CHRNA4, located in a nominal linkage region on chromosome 20q13, 46 was the only gene we included within the nicotinic system. From both single-marker and haplotype analyses, we replicated the associations for the 5 0 flanking region of the gene. 20 Although it is unclear if DSM-IV subtypes are genetically distinct, evidence from twin studies 47, 48 and a recent prospective study 49 suggest both cross-subtype and subtype-specific genetic effects for ADHD. Molecular genetic studies have provided some support for the subtype-specific influences of susceptibility genes for DAT1, 50 CHRNA4, 51 COMT, 52 DRD5 53 and HTR1B. 54 Our findings did suggest the possibility of some specific effects. That is, MAOA, DDC, SYP and CHRNA4 were associated primarily to the ADHD inattentive type, whereas ADRA2C, NET1 and DRD3 exhibited associations mainly to combined type ADHD. In particular for CHRNA4, together with the evidence from Todd and colleagues, 51 this result implies that variations of this gene appear to be involved in the regulation of inattentive ADHD. More extensive investigations are warranted to provide explicit evidence for the differential associations with ADHD constituent subtypes.
DAT1 and DRD4 have repeatedly been implicated in the etiology of ADHD. In our sample, one SNP (rs27072) in DAT1, lying within the 3 0 -UTR region implicated by other studies, displayed a trend for association with nominal significance of 0.051. We found no evidence of association for DRD4. These findings are consistent with our previous report of a failure to replicate prior associations to ADHD for VNTR polymorphisms in DAT1 and DRD4 in the Han population. 55 We had suggested genetic heterogeneity among ethnic backgrounds as a primary source of that lack of consistency with Caucasian samples. At present, ethnic heterogeneity might still act as one of the factors contributed to the discrepancies. An alternative interpretation would be our low possibility of including the directly functional loci of DAT1 and DRD4, since no more than 10 SNPs for each of them were involved in this screen. Nevertheless, considering the trend finding for DAT1 and the potential difficulties of detecting the small effect sizes of DAT1 and DRD4
2 by using the current sample size, we cannot yet refute their role in conferring vulnerability to ADHD.
Our results should be viewed in the context of several limitations. First, given the complexity and heterogeneity nature of ADHD, 56 our sample size is insufficient to reliably detect small genetic effects, especially for subtype analyses. Second, in general, case-control analysis might introduce potential population stratification artifacts, which can consequently bias association tests. 57 However, we have made efforts to ensure our cases to be tested against ethnically matched controls by restricting both groups to the Han origin. Third, although phenotypic diagnoses for cases were completed by highly experienced psychiatrists, our assessment of controls relied primarily on self-report of ADHD symptoms. However, to minimize the potential for under-detection, 18 we set an upper limit to at most three symptoms on each domain.
In conclusion, our comprehensive analysis of 23 candidate genes has identified several genes involved in the regulation of monoamine neurotransmission that may be associated with ADHD. MAOA is a promising susceptibility locus that could play a role in the genetic etiology of this complex disorder. As for SYT1 this analysis, for the first time as far as we are aware, indicates a likely involvement in ADHD features. The current results need to be replicated in other Han samples with a family-based strategy and larger sample size. Furthermore, given the present work is comparable to a portion of the IMAGE project, 20 the overlap of the observed associations, with regard to MAOA, DDC, NET1, SNAP25, SYP and CHRNA4 may reflect their generalizability to both Caucasian and Chinese Han populations. These genes deserve more extensive investigations to improve our understanding of their role in risk for ADHD.
